menu
    • menu

    Company profile for Myosin Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells. Molecular motors are an under-exploited area of disease treatment, including cancer. Our mission to treat significant unmet medical needs is supported by a team with decades of experience in hit to lead discover...
    Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells. Molecular motors are an under-exploited area of disease treatment, including cancer. Our mission to treat significant unmet medical needs is supported by a team with decades of experience in hit to lead discovery, optimization and therapeutic development to the clinic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Myosin TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    130 Scripps Way Jupiter, FL 33458
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.myosintherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Myosin Therapeutics to Present at BIOCOM Global Conference
    Myosin Therapeutics to Present at BIOCOM Global Conference

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-invited-to-present-at-biocom-californias-global-partnering--investor-conference-302674534.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Myosin Pharma Granted FDA Fast Track For MT-125 In Glioblastoma
    Myosin Pharma Granted FDA Fast Track For MT-125 In Glioblastoma

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-receives-fda-fast-track-designation-for-mt-125-in-glioblastoma-302591816.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share
    Myosin Gets $4.5M NCI Grant for MT-125 Glioblastoma Trial
    Myosin Gets $4.5M NCI Grant for MT-125 Glioblastoma Trial

    19 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-awarded-4-5-million-nci-bridge-grant-to-advance-phase-i-trial-of-mt-125-in-glioblastoma-302533661.html

    PR NEWSWIRE
    19 Aug 2025
    Share Share
    Myosin Therapeutics Publishes Two Foundational Studies in Journal
    Myosin Therapeutics Publishes Two Foundational Studies in Journal

    07 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-publishes-two-foundational-studies-in-the-journal-cell-highlighting-a-novel-approach-to-treating-cancer-and-brain-disorders-302498972.html

    PR NEWSWIRE
    07 Jul 2025
    Share Share
    Myosin Gets FDA Nod for 1st Human Trial of MT-125 in Glioblastoma
    Myosin Gets FDA Nod for 1st Human Trial of MT-125 in Glioblastoma

    09 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-receives-fda-clearance-to-initiate-first-in-human-trial-of-mt-125-in-glioblastoma-302475329.html

    PR NEWSWIRE
    09 Jun 2025
    Share Share
    Myosin Therapeutics gets $3M NIH grant for MT-110 trial
    Myosin Therapeutics gets $3M NIH grant for MT-110 trial

    29 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myosin-therapeutics-awarded-3-million-nih-grant-to-advance-clinical-trial-for-mt-110-in-methamphetamine-use-disorder-302438616.html

    PR NEWSWIRE
    29 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search